Patient Safety in Drug Label Design: Analysis of Reported Adverse Events Before and After Introducing a New Label Design

European Journal of Hospital Pharmacy: Science and Practice - Belgium
doi 10.1136/ejhpharm-2012-000274
Full Text
Abstract

Available in full text

Categories
Pharmacy
Date
Authors
Publisher

BMJ

Related search

Patient-Reported and Actionable Safety Events in CKD

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Identifying Adverse Events After Outpatient Surgery: Improving Measurement of Patient Safety

BMJ Quality and Safety
MedicineHealth Policy
2015English

Pcn379 - Quantitative Comparison of the Influence of Open Label Trial Design on Patient Reported Outcome Responses – A Metastatic Melanoma Case Study.

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Improvement in Patient-Reported Outcomes After Rituximab in Rheumatoid Arthritis Patients: An Open-Label Assessment of 175 Patients

Joint Bone Spine
Rheumatology
2015English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

A New Label for Mifepristone

New England Journal of Medicine
Medicine
2016English

Intraoperative Reported Adverse Events in Children

Paediatric Anaesthesia
Child HealthPediatricsAnesthesiologyPain MedicinePerinatology
2009English

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy